Target intelligence / Profile preview

T-cell receptor specific for MHC-presented ESAT-6 and CFP-10 peptides (TCR (ESAT-6/CFP-10))

Target
TCR (ESAT-6/CFP-10)
Molecular classification
Receptor, Immune system protein, Heterodimeric protein complex
01

Overview

The T-cell receptor (TCR) specific for MHC-presented ESAT-6 and CFP-10 peptides is a pivotal mediator of the cellular immune response against Mycobacterium tuberculosis (Mtb). ESAT-6 (Early Secretory Antigenic Target 6 kDa) and CFP-10 (Culture Filtrate Protein 10 kDa) are highly immunogenic proteins secreted by Mtb via the ESX-1 secretion system and are notably absent in the Mycobacterium bovis BCG vaccine strain (Brodin et al., 2004, Trends in Microbiology). These antigens are processed by antigen-presenting cells and displayed on Major Histocompatibility Complex (MHC) molecules, where they are recognized by specific TCRs on CD4+ and CD8+ T-lymphocytes (Andersen, 2001, Trends in Immunology). This interaction triggers the release of protective cytokines such as interferon-gamma (IFN-gamma) and tumor necrosis factor-alpha (TNF-alpha), which activate macrophages to contain or eliminate the intracellular pathogen (Kaufmann, 2013, Seminars in Immunology). Consequently, this TCR-antigen complex is a primary focus for the development of next-generation tuberculosis vaccines, such as H56:IC31, and serves as the biological basis for highly specific diagnostic Interferon-Gamma Release Assays (IGRAs) (Pai et al., 2014, Clinical Microbiology Reviews).

Other names
ESAT-6/CFP-10 specific T-cell receptorTCR-MHC-ESAT6-CFP10 complexMycobacterium tuberculosis antigen-specific T-cell receptorESAT-6/CFP-10-reactive TCR
02

Mechanism of action

Activation of antigen-specific T-cells to induce a protective Th1 immune response and cytokine production (IFN-gamma, TNF-alpha) against Mycobacterium tuberculosis.

03

Biological functions

Antigen recognitionT-cell activationImmune responseCytokine productionCell-mediated immunity
04

Disease associations

InfectionTuberculosis
05

Safety considerations

Cytokine release syndrome (theoretical for TCR-T therapies)Immune exhaustionMHC restriction (limited efficacy across diverse populations)Potential for excessive pulmonary inflammation
06

Interacting drugs

H56:IC31

4 more in the full profile.

07

Biomarkers

Interferon-gamma (IFN-gamma) releaseESAT-6/CFP-10 specific T-cell frequencyCD4+ T-cell proliferationTNF-alpha levels

Beyond the preview

Go deeper on T-cell receptor specific for MHC-presented ESAT-6 and CFP-10 peptides (TCR (ESAT-6/CFP-10)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T-cell receptor specific for MHC-presented ESAT-6 and CFP-10 peptides (TCR (ESAT-6/CFP-10)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call